Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.


Overview | Financials
Company Name Olema Pharmaceuticals, Inc.
Symbol OLMA
Currency USD
Price 9.84
Market Cap 550,388,592
Dividend Yield 0%
52-week-range 5.02 - 17.791
Industry Biotechnology
Sector Healthcare
CEO Dr. Sean P. Bohen M.D., Ph.D.
Website https://www.olema.com

An error occurred while fetching data.

About Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or

Related Stocks

Poseida Therapeutics, Inc. logo

Poseida Therapeutics, Inc.


3.19 USD

MDxHealth SA logo

MDxHealth SA


2.375 USD

MediciNova, Inc. logo

MediciNova, Inc.


1.42 USD

Shattuck Labs, Inc. logo

Shattuck Labs, Inc.


7.915 USD

OncoCyte Corporation logo

OncoCyte Corporation


2.93 USD


Numbers are in millions USD

Numbers are in millions USD